Bromocriptine Mesylate Capsule
Product Images NDC 0378-7096

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Bromocriptine Mesylate (NDC 0378-7096). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Mylan Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Bromocriptine Mesylate Capsules, Usp 2.5 mg Bottle Label (Image 01)

Chemical structure of bromocriptine mesylate showing the detailed molecular arrangement, including the bromine atom, multiple rings, and the mesylate component. Molecular formula is C32H40BrN5O5·CH4SO3 with a molecular weight of 750.71.*

FDA Label Image

Bromocriptine Mesylate Capsules, Usp 5 mg Bottle Label (Image 02)

Label for Bromocriptine Mesylate Capsules, USP 5 mg by Mylan Pharmaceuticals Inc. The label indicates the product is prescription only (Rx only) and contains 30 capsules. Instructions include storing at 20 to 25°C and keeping medication out of reach of children. The NDC is 0378-7096-93, and the label emphasizes dispensing in a tight, light-resistant container with a child-resistant closure.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.